Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Etonogestrel. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR known ✓ | P06401 | 8/20 | 1.00 |
| ▸ | SHBG | P04278 | 9/20 | 1.00 |
| ▸ | ESR1 | P03372 | 6/20 | 1.00 |
| ▸ | AR | P10275 | 6/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.72 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.72 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.72 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.72 |
| ▸ | DRD1 | P21728 | 1/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.72 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.72 |
| ▸ | CCKBR | P32239 | 1/20 | 0.72 |
| ▸ | DRD3 | P35462 | 1/20 | 0.72 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 5/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etonogestrel SCHEMBL1649327 | 1.00 | SHBG (1.00) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL19510085 | 1.00 | SHBG (1.00) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL484265 | 1.00 | SHBG (1.00) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL6462179 | 1.00 | SHBG (1.00) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL117703 | 1.00 | SHBG (1.00) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL28648883 | 0.99 | SHBG (0.98) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL14941286 | 0.93 | SHBG (0.87) | SHBGPGRESR1AROPRM1 | |
| SCHEMBL20851741 | 0.93 | SHBG (0.86) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL5023860 | 0.90 | SHBG (0.81) | SHBGPGRESR1AROPRM1 | |
| Etonogestrel SCHEMBL6150744 | 0.90 | SHBG (0.81) | SHBGPGRESR1AROPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11034716-B2 | Process and new intermediates for the preparation of 11-methylene steroids | CRYSTAL PHARMA, S.A.U. (ES) | 2021-06-15 | — | — | US | disclosed |
| EP-3423464-B1 | PROCESS AND NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS | CRYSTAL PHARMA SAU (ES) | 2021-05-26 | — | — | EP | disclosed |
| US-20190092807-A1 | PROCESS AND NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS | CURIA SPAIN, S.A.U. (ES) | 2019-03-28 | — | — | US | disclosed |
| US-9464108-B2 | Combined synthesis route for desogestrel and etonogestrel | MERCK SHARP & DOHME B.V. (NL) | 2016-10-11 | — | — | US | disclosed |
| US-9464108-B2 | Combined synthesis route for desogestrel and etonogestrel | MERCK SHARP & DOHME B.V. (NL) | 2016-10-11 | — | — | US | disclosed |
| EP-2892909-B1 | PROCESS FOR THE PREPARATION OF 11-METHYLENE-18-METHYLESTR-4-EN-3,17-DIONE, USEFUL AS AN INTERMEDIATE IN THE SYNTHESIS OF COMPOUNDS WITH PHARMACOLOGICAL ACTIVITY. | IND CHIMICA SRL (IT) | 2016-08-24 | — | — | EP | disclosed |
| US-9422326-B2 | Process for preparing 11-methylene-18-methyl-estr-4-en-3, 17-dione, useful as intermediate compound for the synthesis of molecules having pharmacological activity | INDUSTRIALE CHIMICA S.R.L. (IT) | 2016-08-23 | — | — | US | disclosed |
| US-9422326-B2 | Process for preparing 11-methylene-18-methyl-estr-4-en-3, 17-dione, useful as intermediate compound for the synthesis of molecules having pharmacological activity | INDUSTRIALE CHIMICA S.R.L. (IT) | 2016-08-23 | — | — | US | disclosed |
| US-20150239925-A1 | Process for Preparing 11-Methylene-18-Methyl-Estr-4-En-3, 17-Dione, Useful as Intermediate Compound for the Synthesis of Molecules Having Pharmacological Activity | INDUSTRIALE CHIMICA S.R.L. (IT) | 2015-08-27 | — | — | US | disclosed |
| US-20150239925-A1 | Process for Preparing 11-Methylene-18-Methyl-Estr-4-En-3, 17-Dione, Useful as Intermediate Compound for the Synthesis of Molecules Having Pharmacological Activity | INDUSTRIALE CHIMICA S.R.L. (IT) | 2015-08-27 | — | — | US | disclosed |
| US-20150031875-A1 | COMBINED SYNTHESIS ROUTE FOR DESOGESTREL AND ETONOGESTREL | ORGANON BIOSCIENCES NEDERLAND B.V. (NL) | 2015-01-29 | — | — | US | disclosed |
| US-20150031875-A1 | COMBINED SYNTHESIS ROUTE FOR DESOGESTREL AND ETONOGESTREL | ORGANON BIOSCIENCES NEDERLAND B.V. (NL) | 2015-01-29 | — | — | US | disclosed |
| WO-2014037873-A1 | PROCESS FOR PREPARING 11 -METHYLENE-18-METHYL-ESTR-4-EN-3, 17- DIONE, USEFUL AS INTERMEDIATE COMPOUND FOR THE SYNTHESIS OF MOLECULES HAVING A PHARMACOLOGICAL ACTIVITY | INDUSTRIALE CHIMICA S.R.L. (IT) | 2014-03-13 | — | — | WO | disclosed |
| WO-2013135744-A1 | COMBINED SYNTHESIS ROUTE FOR ETONOGESTREL AND DESOGESTREL | MSD OSS B.V. (NL) | 2013-09-19 | — | — | WO | disclosed |
| WO-2013071210-A1 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL | EVESTRA, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130123523-A1 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL | EVESTRA, INC. | 2013-05-16 | — | — | US | disclosed |
| US-20130123523-A1 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL | EVESTRA, INC. | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031875-A1 | COMBINED SYNTHESIS ROUTE FOR DESOGESTREL AND ETONOGESTREL | CYP19A1, CYP17A1, CYP2A6 | PGR 16/4885SHBG 31/4885ESR1 79/4885 |
| US-11034716-B2 | Process and new intermediates for the preparation of 11-methylene steroids | CYP17A1, HSD17B11, CYP19A1 | PGR 38/4885SHBG 25/4885ESR1 99/4885 |
| US-20190092807-A1 | PROCESS AND NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS | CYP19A1, CYP17A1, HSD17B11 | PGR 29/4885SHBG 31/4885ESR1 79/4885 |
| US-20130123523-A1 | METHODS FOR THE PREPARATION OF ETONOGESTREL AND DESOGESTREL | GNRHR, CYP19A1, HSD17B11 | PGR 7/4885SHBG 4/4885ESR1 26/4885 |
| US-20150239925-A1 | Process for Preparing 11-Methylene-18-Methyl-Estr-4-En-3, 17-Dione, Useful as Intermediate Compound for the Synthesis of Molecules Having Pharmacological Activity | CYP19A1, HSD17B11, CYP17A1 | PGR 18/4885SHBG 13/4885ESR1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.